Oxalosis and Hyperoxaluria Foundation

Recent papers from Oxalosis and Hyperoxaluria Foundation

1. Kidney-Alone Transplantation with siRNA Therapy in Primary Hyperoxaluria Type 1Kidney International Reports · 2026
2. Interleukin-17A mediates cardiorenal injury in oxalate nephropathyCardiovascular Research · 2026
3. WCN26-4399 KIDNEY-ALONE TRANSPLANTATION WHILE ON siRNA THERAPY FOR PRIMARY HYPEROXALURIA TYPE 1: A MULTINATIONAL RETROSPECTIVE CASE SERIES FROM THE PH1NITx WORKING GROUPKidney International Reports · 2026
4. RNA interference medication and transplantation procedures in patients with primary hyperoxaluria type 1 (PH1)Nephrology Dialysis Transplantation · 2025
5. Normative urinary excretion parameters for early identification of primary hyperoxaluria or other kidney stone associated diseases in infants < 8 weeks of life2025
6. A Patient-Prioritized Research Agenda for Clinical Trials in Kidney Stone DiseaseThe Journal of Urology · 2024
7. Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1Kidney International Reports · 2023
8. End Point Considerations for Clinical Trials in Enteric HyperoxaluriaClinical Journal of the American Society of Nephrology · 2023
9. Chronic liver disease and hepatic calcium-oxalate deposition in patients with primary hyperoxaluria type IScientific Reports · 2022
10. Improving Treatment Options for Primary HyperoxaluriaDrugs · 2022
11. Chronic liver disease and hepatic calcium-oxalate deposition in patients with primary hyperoxaluria type I2022
12. Diet-related urine collections: assistance in categorization of hyperoxaluriaUrolithiasis · 2021
13. Primary HyperoxaluriaClinical Journal of the American Society of Nephrology · 2020
14. End Points for Clinical Trials in Primary HyperoxaluriaClinical Journal of the American Society of Nephrology · 2020
15. Inherited conditions resulting in nephrolithiasisCurrent Opinion in Pediatrics · 2019